Roche erhält EU-Zulassung für PiaSky has seltene Blutkrankheit

DJ Roche has selected the EU approval for PiaSky for Blutkrankheit

By Ian Walker

BRUSSELS (Dow Jones)–Roche has promised a follow-up approval in the European Union. The Commission has developed the drug PiaSky as an injection. It is a fact that part of the blood-paroxysmal nocturnal haemoglobinuria (PNH) falls under the control of the stops. If a phase III research study is carried out, the drug will be replaced with part of the subcutaneous injection.

In PNH, one of the most important diseases, the blood sugar level was affected by the immune system itself, which can cause fatigue, tiredness and fainting. Potenziell can lead to a lower illness.

Contact the author: [email protected]

DJG/DJN/mgo/cbr

(END) Dow Jones Newswires

August 27, 2024 01:51 ET (05:51 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.